Aequs, the contract manufacturing company, has received board approval to raise up to ₹650 crore through a preferential issue, according to people familiar with the development. The proposed capital infusion is expected to support the company's manufacturing expansion plans and provide additional balance-sheet flexibility as it positions itself for larger production volumes and deeper customer relationships.
The move comes at a time when India's manufacturing-focused startups are under pressure to demonstrate both scale and operating discipline. Unlike software-led ventures that can expand with relatively limited capital, contract manufacturers typically require sustained investment in plant, machinery, tooling, quality systems and working capital. Aequs' decision to tap equity capital through a preferential issue suggests the company is prioritising long-term capacity creation over short-term leverage.
Capacity First Strategy
A preferential issue allows a company to raise funds from identified investors without going through a public market process, making it a faster and more targeted route to capital. For a business such as Aequs, which operates in a capital-intensive segment, the structure can be useful for funding expansion while bringing in investors aligned with the company's manufacturing roadmap.
The size of the proposed raise, up to ₹650 crore, is notable in the context of India's startup and venture capital market, where large equity rounds have increasingly been reserved for businesses with clear industrial moats or strong revenue visibility. Aequs appears to fit that profile. Contract manufacturing, particularly in sectors that demand precision, compliance and repeat orders, can create durable customer stickiness if execution remains consistent.
The company's focus on capacity expansion also reflects a broader shift in how investors are viewing manufacturing-led ventures. After years in which capital largely chased consumer internet and software models, there is now greater interest in businesses that can plug into global supply chains, support import substitution and benefit from India's push to deepen domestic manufacturing capabilities.
Capital For Scale-Up
For Aequs, fresh capital could help accelerate investments across production infrastructure, automation and operational readiness. In contract manufacturing, the ability to scale is often constrained not by demand alone but by the speed at which a company can add certified capacity, maintain quality standards and manage procurement efficiently. Additional funds can therefore have a direct impact on revenue potential, margin stability and customer acquisition.
The raise may also improve the company's ability to absorb working-capital needs that typically rise with order growth. Manufacturing businesses often face a lag between raw material purchases, production cycles and customer payments, making liquidity management a central part of the operating model. Equity capital can reduce dependence on debt and provide more room to execute expansion plans without immediate refinancing pressure.
While the board approval marks an important step, the final contours of the transaction, including investor participation and pricing, will determine how much strategic value the raise delivers. Preferential issues are often closely watched because they can signal both confidence from incoming investors and the company's valuation expectations.
Manufacturing Bets Deepen
The development also highlights the continuing evolution of India's startup ecosystem beyond digital-first companies. Manufacturing platforms such as Aequs are increasingly seen as part of the country's industrial growth story, especially as global companies diversify sourcing away from concentrated supply chains and look for reliable partners in India.
If executed successfully, the fundraise could strengthen Aequs' position in a market where scale, execution and customer trust are critical. It would also reinforce the view that venture and growth capital is willing to back businesses with long gestation periods, provided they can demonstrate a credible path to capacity expansion and commercial durability.
For now, the board's approval signals intent: Aequs is preparing to raise significant capital to build more manufacturing muscle. In a sector where physical assets and operational precision matter as much as strategy, that may prove to be the most important signal of all.